Advertisement
Trending - Altmetric
-
Gedatolisib shows superior potency and efficacy versus single-node PI3K/AKT/mTOR inhibitors in breast cancer models
-
Antibody-drug conjugates for treating early-stage breast cancer: current use, anticipated evolutions
-
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
-
The untapped potential of radiation and immunotherapy for hormone receptor-positive breast cancer